找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Esophageal Cancer; Diagnosis and Treatm Francisco Schlottmann,Lorenzo Ferri,Marco G. Patti Textbook 2023Latest edition The Editor(s) (if ap

[复制链接]
楼主: Strategy
发表于 2025-3-30 11:06:51 | 显示全部楼层
发表于 2025-3-30 15:56:51 | 显示全部楼层
发表于 2025-3-30 16:45:13 | 显示全部楼层
发表于 2025-3-30 22:38:01 | 显示全部楼层
发表于 2025-3-31 02:02:03 | 显示全部楼层
Asha Humbal,Neha Chaudhary,Bhawana Pathakntly, the potentially reduced quality of life, endoscopic therapy represents a favorable approach where appropriate. Endoscopic resection therapies have been successfully applied to selected patients with early tumors of the esophagus with equivalent oncological outcomes. This chapter will address t
发表于 2025-3-31 07:11:57 | 显示全部楼层
Advances in Global Change Researche two diseases entities should be treated differently. It is clear that chemotherapy or chemoradiotherapy should be given before surgery; however, perioperative systemic regimens have taken over the landscape for patients with EAC in many centers around the world. Although significant regional diffe
发表于 2025-3-31 09:52:14 | 显示全部楼层
Mohammed H. I Dore,Peter Simciskodiotherapy (dCRT) is at least equivalent to trimodality therapy in terms of long-term survival for patients with esophageal squamous cell carcinoma (ESCC). Frail patients with ESCC who are not fit for surgery should receive dCRT. For those who are considered fit for esophagectomy, decision between d
发表于 2025-3-31 16:58:09 | 显示全部楼层
Kenneth D. Frederick,David C. Majorhe biology and the potential role of identifying biomarkers of response, and offers a comprehensive overview of the clinical trials that have evaluated the use of immunotherapy in different settings of the treatment of esophageal cancer.
发表于 2025-3-31 18:35:32 | 显示全部楼层
发表于 2025-4-1 00:13:55 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-11 03:33
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表